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Abstract
This is the first case report of Histiocytic Sarcoma (HS) with predominant spindle cell component
occurring in the head and neck region of a 41-year-old man. The tumor was composed of sheets
of large round to oval cells with pleomorphic vesicular nuclei, prominent nucleoli and abundant
eosinophilic cytoplasm. Multinucleated forms, numerous mitoses, and tumor necrosis were also
noted. Sheets, fascicles, and whorls of spindle cells with spindled to ovoid vesicular nuclei, small to
medium-sized distinct nucleoli, and eosinophilic cytoplasm were frequently observed.
Immunohistochemical staining in the tumor cells was positive for CD163, CD68, lysozyme, CD45,
and NSE. Focal expression of CD4 and S-100 was also noted. Electron microscopy demonstrated
an abundance of lysosomes in the cytoplasm of tumor cells. Chromosome study revealed a 57–80
hyperdiploid [7]/46, XY [13] karyotype, including 3 to 4 copies of various chromosomes. The
immunohistochemical and ultrastructural findings confirmed the diagnosis of HS.
Background
Histiocytic sarcoma (HS) is rare neoplasm characterized
by malignant proliferation of cells showing morphologic
and immunophenotypic features similar to those of
mature tissue histiocytes [1]. Most patients are adults
(median age 46 years). Male predilection is found in some
studies [1]. About one-third of cases present in lymph
nodes, about one-third in skin, and about one-third in a
variety of other extranodal sites, most commonly the
intestinal tract [1]. Awareness of HS is important, as the
tumor closely mimics other lymphoid tissue malignancies
in their clinical presentation and morphologic appear-
ance. We present a case of HS of the head and neck which
was initially identified only as malignant spindle cell
tumor not further classifiable. To our knowledge, a case of
HS with predominant spindle cell component has never
been reported before. We describe the histologic, immu-
nohistochemical, and ultrastructural features, as well as
the cytogenetics of a HS with unusual differentiation.
Case presentation
In October of 2006 a 41-year-old otherwise healthy man
presented to the University of Maryland, Department of
Oral and Maxillofacial Surgery for an evaluation of an
expansile mass in the left zygomatic, preauricular region.
Five months earlier the patient complained of headaches
and increasing fatigue at the end of a normal work day. He
then noticed increasing left jaw pain and trismus along
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with the headaches. He was seen and evaluated by his pri-
mary care physician. Initially he was treated for temporo-
mandibular disorder. However, the patient's symptoms
failed to subside and subsequently he was referred to an
oral and maxillofacial surgeon. Computed tomography of
his head and neck was obtained, revealing a destructive
mass in the left condyle (Fig. 1). He was subsequently
referred to the University of Maryland Medical Center for
definitive treatment.
Examination of the patient revealed slight facial asymme-
try with a nontender, slightly indurated mass in the left
zygomatic, preauricular region. Further examination pro-
duced questionable paresthesia in the distribution of the
maxillary division of the left trigeminal nerve. No facial
nerve weakness was appreciated. Evaluation of the axial
and coronal CTs revealed a 4.0 cm soft tissue mass involv-
ing the neck of the left condyle, infiltrating the masseter
and pterygoid muscles. A whole body PET scan showed
increased metabolic activity (SUV 9.2) in the left condyle.
No other abnormal activity was seen in the neck, chest,
abdomen or pelvis. Laboratory findings: WBC: 4.7 K/mcL,
HGB: 13.9 g/dl, HCT: 41.0%, RBC: 4.77 M/mcL, Platelets:
308000 K/mcL. An open biopsy was performed in the
operating room via a preauricular incision and a patho-
logical diagnosis of malignant spindle cell tumor was
made.
In view of the diagnosis of sarcoma the patient subse-
quently underwent a vertical compartment resection with
exposure via hemicoronal incision extending to a modi-
fied Blair incision. The specimen was removed en-bloc
with a margin of normal tissue, preserving the facial nerve.
The patient was primarily reconstructed with a microvas-
cular free fibula flap from the contralateral leg. He was
extubated on post-operative day one, and discharged from
the intensive care unit on post-operative day three. The
rest of his hospital course was uneventful and he was dis-
charged on post-operative day seven. Following the final
pathologic diagnosis he was discussed at the institutional
tumor board and recommended for adjunctive radiother-
apy.
Methods
Gross
Gross examination of the specimen revealed a relatively
well circumscribed firm mass (5.6 × 4.2 × 3.2 cm) with
yellow-tan cut surface focally infiltrating soft tissue and
skeletal muscle, abutting the underlying bone. Areas of
necrosis were identified.
Histology
The resected tissues were fixed in 10% buffered formalin
and embedded in paraffin. Subsequently, the tissue
blocks were sectioned at a thickness of 5 microns and
stained with hematoxylin-eosin.
Immunohistochemistry
Immunohistochemical staining was performed using
Ventana Enhanced DAB Detection Kit and Biotin-StreptA-
vidin (B-SA) amplified methodology (Ventana, Tucson,
AZ) and commercially available prediluted monoclonal
antibodies against the following antigens: CD163 (Neo-
Markers), CD4 (Biocare Medical), lysozyme, CD1a, CD3,
CD8, CD20, CD21, CD23, CD30, CD43, CD45, CD68,
CD99, CD117, ALK, S-100 protein, neuron specific eno-
lase (NSE), smooth muscle actin, desmin, vimentin, myo-
genin, EMA, LMP-1, HMB45, Mart-1/Melan A, TTF1,
pancytokeratin, CK 903, CAM 5.2, and Ki-67 (all Ventana,
Tucson, AZ).
In situ hybridization for detection of Epstein-Barr virus
Epstein-Barr (EBV) infection status was analyzed by in situ
hybridization for EBV-encoded RNAs using an Epstein-
Barr Early RNA Probe Reagent (EBER 1–2, Ventana
INFORM EBER, Tucson, AZ).
Electron microscopy
Representative tissue samples (1 mm cubes) were fixed in
4F1G for 4 hours, postfixed in osmium tetroxide, dehy-
Histiocytic sarcoma Figure 1
Histiocytic sarcoma. Axial CT scan showing a destructive 
lesion of the left mandible with invasion of the surrounding 
musculature.Diagnostic Pathology 2007, 2:7 http://www.diagnosticpathology.org/content/2/1/7
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drated in graded alcohols, and embedded in epoxy resin.
The sections were stained with uranyl acetate and lead cit-
rate and examined on a JEM 1200 transmission electron
microscope.
Chromosome study
Cells were dispersed and cultured in RPMI 1640 medium
with 20%fetal bovine serum for 24 and 48 hours, respec-
tively. Metaphase cells were analyzed following standard
G-banding method. Their karyotypes were interpreted
according to the International System for Human Cytoge-
netic Nomenclature.
Results
Hematoxylin-eosin stained sections showed a tumor mass
remotely resembling a completely effaced lymph node,
composed of a diffuse proliferation of large round to oval
cells with pleomorphic vesicular nuclei, prominent nucle-
oli and abundant eosinophilic cytoplasm (Fig. 2). Sheets,
fascicles, and whorls of spindle cells with spindled to
ovoid vesicular nuclei, small to medium, distinct nucleoli,
and eosinophilic cytoplasm were frequently observed
(Fig. 3). Large multinucleated cells, mitotic figures (27/10
HPFs), and necrosis were also noted. There were numer-
ous admixed lymphocytes, polymorphonuclear leuko-
cytes, and less commonly, plasma cells. The neoplastic
cells invaded the lymph node capsule, perinodal soft tis-
sues and periosteum. They were strongly positive for
CD163 (Fig. 4), CD68, lysozyme, NSE, and vimentin.
Weak to moderate immunostaining for S-100, CD4, and
CD45 were also noted. Reactive lymphocytes stained
strongly for CD3, CD4, CD8, and to a lesser degree for
CD20. Residual CD21 positive, and CD23 positive follic-
ular dentritic cells were also seen (Fig. 5). The Ki-67 index
was approximately 70% (Fig. 6). The neoplastic cells were
negative for CD43, ALK, CD30, EMA, smooth muscle
actin, cytokeratin, desmin, myogenin, TTF1, CD99, CD1a,
LMP-1, CD117, HMB45, and Mart-1/Melan A. Electron
microscopy revealed presence of numerous lysosomes
and lack of desmosomes, Birbeck granules and interdigi-
tating cell processes (Fig. 7). In situ hybridization for EBV-
encoded RNAs was negative. Cytogenetic studies revealed
a 57–80 hyperdiploid [7]/46, XY [13] karyotype, includ-
ing 3 to 4 copies of various chromosomes.
Discussion
Histiocytic and dendritic cell sarcomas are among the rar-
est of tumors affecting lymphoid tissues [1-5]. These
tumors arise from phagocytes and related accessory cells,
which have major roles in the processing and presentation
of antigens to lymphocytes. Currently, the WHO includes
the following 5 entities under this designation: histiocytic
sarcoma (HS), follicular dendritic cell sarcoma (FDCS),
interdigitating dendritic cell sarcoma (IDCS), Langerhans
cell sarcoma (LCS), and dendritic cell sarcoma, not other-
wise specified (DCS, NOS)[1]. The pathologic diagnosis
of HS is often challenging and requires histologic, immu-
nohistochemical, and, occasionally, electron microscopic
analysis [1-5]. We reached the diagnosis of HS in our case
based on the exclusion of other sarcomas and carcinomas
including other members of the HS/dendritic cell sarcoma
group. A comparison between immunophenotypes and
ultrastructural features of the neoplastic cells of present
case and reported lymphoid tissue phagocytic and acces-
sory cell neoplasms is shown in Table 1.
Histologically, the tumor showed diffuse infiltrate of
large, round to ovoid pleomorphic cells; large multinucle-
ated forms, mitoses, and necrosis were commonly seen.
Interestingly, our case showed an uncommon phenotype,
namely a prominent spindle cell component, causing sig-
nificant diagnostic confusion with other spindle cell neo-
plasms. The neoplastic cells demonstrated
immunohistochemical staining characteristics similar to
those of normal monocytes/histiocytes, namely strong
immunoreactivity with CD163, CD68, lysozyme, NSE,
and vimentin. In addition, there was focal expression of S-
100 protein, CD45, and CD4, reflecting the physiologic
pattern of expression of this T-helper antigen by histio-
cytes [1]. Electron microscopy revealed presence of
numerous lysosomes and lack of desmosomes, Birbeck
granules and prominent interdigitating cell processes.
Histiocytic sarcoma with a prominent spindle cell compo-
nent has morphologic similarity with IDCS. The latter
consistently expresses S-100 protein, ATPase and HLA-
DR, and is variably, weakly positive for CD68, lysozyme,
and CD45 [1,5-8]. Unlike HS, IDCS cells do not express
non-specific esterases [1]. In addition, cytologic atypia
and mitotic rate are low, and necrosis is usually absent [1].
On electron microscopy, IDDCS cells show long cytoplas-
mic finger-like projections and lack the abundance of lys-
osomes – a characteristic ultrastructural feature of
histiocytes.
In the case presented here, considering the morphologic
features, the neoplasm should also be differentiated from
a LCS. The neoplastic cells of LCS display overtly malig-
nant cytology and linear nuclear grooves reminescent of
Langerhans cell histiocytosis, a key feature to suggest this
diagnosis [1]. The neoplastic cells consistently express S-
100 protein, and, unlike HS, CD1a [1,5,9]. In addition,
there is usually some immunostaining for CD68, lys-
ozyme, and CD45. On electron microscopy, Birbeck gran-
ules and a variable number of lysosomes should
theoretically be present in all cases in which adequate
examination was carried out [1].
Spindle to ovoid cell proliferation with occasional multi-
nucleated cells can be observed in FDCS [1,5,10-12]. TheDiagnostic Pathology 2007, 2:7 http://www.diagnosticpathology.org/content/2/1/7
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neoplasm forms fascicles, storiform patterns, and whorls
[1]. The neoplastic cells are strongly positive for one or
more of the follicular dendritic cell markers, including
CD21, CD23, and CD35. In addition, they express vimen-
tin, fascin, clusterin, HLA-DR, and are variably positive for
EMA, S-100 protein, and CD68 [1,11]. Follicular dendritic
cell sarcoma may occur in association with Castleman dis-
ease, usually the hyaline vascular type [1]. A high propor-
tion of cases of putative FDCS showing features of
inflammatory pseudotumor have been associated with
the Epstein-Barr virus [1,12]. In these cases, Epstein-Barr
virus encoded RNA (EBER) has been found in all of the
spindle cells [1]. In the case presented here, all neoplastic
cells were negative for Epstein-Barr encoded RNA. Elec-
tron microscopically, the most distinctive ultrastructural
feature of FDCS is the presence of numerous long, slender
cytoplasmic processes connected by desmosomes.
Dendritic cell sarcoma, NOS, can mimic a HS with prom-
inent spindle cell component. This is a diagnosis of exclu-
sion, not well characterized morphologically and
immunohistochemically. The neoplastic cells express
Histiocytic sarcoma Figure 2
Histiocytic sarcoma. Diffuse proliferation of large round 
to oval cells with pleomorphic vesicular nuclei, prominent 
nucleoli and abundant eosinophilic cytoplasm. A mitosis is 
seen. (hematoxylin-eosin, original magnification × 400).
Histiocytic sarcoma Figure 3
Histiocytic sarcoma. Note prominent spindle cell differen-
tiation. (hematoxylin-eosin, original magnification × 200).
Histiocytic sarcoma Figure 4
Histiocytic sarcoma. Neoplastic round and spindle cells 
are strongly positive for CD163. (B-SA, anti-CD163, original 
magnification × 400).
Histiocytic sarcoma Figure 5
Histiocytic sarcoma. Residual follicular dendritic cells are 
strongly positive for CD21. (B-SA, anti-CD21, original magni-
fication × 200).Diagnostic Pathology 2007, 2:7 http://www.diagnosticpathology.org/content/2/1/7
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CD1a and S-100 protein but lack cytoplasmic Birbeck
granules [1].
The overall appearance of HS may be indistinguishable
from a diffuse large B-cell lymphoma or an anaplastic
large cell lymphoma. Immunohistochemical markers are
necessary to make a certain lineage distinction. In contrast
to HS, diffuse large B-cell lymphoma constantly express
various pan-B markers such as CD19, CD20, CD22, and
CD79a, while anaplastic large cell lymphomas are posi-
tive for CD30, and ALK [1].
Other tumors, such as carcinomas, melanomas, and soft
tissue sarcomas, primary or metastatic, can be confused
with HS and were excluded in our case by the lack of
immunoreactivity for pancytokeratin, CAM 5.2, CK 903,
TTF1, HMB45, MART-1/Melan A, CD99, CD117, smooth
muscle actin, desmin, and myogenin.
Last but not least, HS may be confused with reticulohisti-
ocytoma – an uncommon, incompletely characterized
benign histiocytic proliferation of the skin and soft tis-
sues. The lesion is composed of epithelioid histiocytes
with abundant, densely eosinophilic cytoplasm, and, in
contrast to HS, mild if any, nuclear atypia and low mitotic
activity [13].
Histiocytic sarcoma is a neoplasm with uncertain molecu-
lar pathogenesis. The neoplasm in our case showed a 57–
80 hyperdiploid [7]/46, XY [13] karyotype, including 3 to
4 copies of various chromosomes. Recent studies estab-
lished a cooperative role of PTEN and p16(INK4A)/
p14(ARF) in the development of HS [4]. In addition, HS
demonstrated germ-like clonal immunoglobulin and T-
cell receptor genes [14].
The biologic behavior of HS is typically aggressive with a
poor response to therapy. In agreement with previous
reports, the HS case presented here demonstrated high
proliferative rate and extranodal spread [1]. Stage of dis-
ease and possibly tumor size are considered significant
prognostic indicators [1]. Most patients die of progressive
disease reflecting the high clinical stage at presentation
[1]. Sarcomas in the head and neck are best treated ini-
tially with surgery to obtain wide surgical margins. This
may be limited due to neurovascular structures within the
head and neck. Hence local recurrence in large sarcomas
is a concern. Radiotherapy has been shown been shown to
be an important adjunctive role in management of tumors
were wide surgical margins are not possible. Chemother-
apy regimens are more controversial. Due to the rarity of
head and neck sarcomas there are no proven regiments.
Most studies are retrospective reviews from different insti-
tutions. Chemotherapy like radiotherapy is used prima-
rily for local control of disease. The patient's overall
prognosis is influenced by grade and the ability to obtain
wide margins, with improved survivability by controlling
local recurrence and distant metastasis [15].
In summary, HS is a rare neoplasm that may pose diffi-
culty in pathologic diagnosis. Awarness of HS is impor-
tant because these neoplasms may mimic other
lymphoproliferative disorders in their clinical presenta-
tion and morphologic appearance. Even with immuno-
histochemical work-up, diagnosis may be missed as
histiocytic markers are often not included in the routine
pannel of antibodies used for investigation of spindle cell
Histiocytic sarcoma Figure 6
Histiocytic sarcoma. Neoplastic cells are strongly positive 
for Ki-67. (B-SA, anti-Ki-67, original magnification × 200).
Histiocytic sarcoma Figure 7
Histiocytic sarcoma. Numerous lysosomes are seen in 
neoplastic cell cytoplasm. (electron microscopy, original mag-
nification × 8000).Diagnostic Pathology 2007, 2:7 http://www.diagnosticpathology.org/content/2/1/7
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and undifferentiated neoplasms. The key feature sugges-
tive of HS is the strong expression of one or more "histio-
cytic markers", including CD163, CD68, and lysozyme in
the majority of neoplastic cells.
Although a few cases of extranodal FDCS have been
described in the head and neck [12], to our knowledge
this is the first case of a HS arising in this area.
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